ArticleInternational journal of molecular sciences2025
Whole Genome Sequencing of Clinical
Yuta Nakagawa, Chie Yamamoto, Hidetake Kawajiri, Makoto Watanabe, Tomomi Yamada, Yukiji Yamada, Daisuke Kambayashi, Keitaro Furukawa, Ryosuke Hamashima, Tetsuhiro Yamano and 5 more
Abstract readCase Reports
In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Yuta NakagawaDepartment of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Chie YamamotoDepartment of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.ORCID 0000-0002-3919-8830 Hidetake KawajiriDivision of Cardiovascular and Paediatric Cardiovascular Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Makoto WatanabeDepartment of Emergency Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.ORCID 0000-0002-0734-4047 Tomomi YamadaDepartment of Clinical Laboratory, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Yukiji YamadaDepartment of Clinical Laboratory, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Daisuke KambayashiCardiovascular Department, Fukuchiyama City Hospital, Fukuchiyama 620-0056, Japan.
Keitaro FurukawaDepartment of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Ryosuke HamashimaDepartment of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Tetsuhiro YamanoDepartment of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.ORCID 0000-0002-2123-6122 Tohru InabaDepartment of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.ORCID 0000-0002-1595-8524 Kunihiko KooguchiDepartment of Critical Care Medicine, University Hospital, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Shinichiro OdaDivision of Cardiovascular and Paediatric Cardiovascular Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Satoshi MitaraiDepartment of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo 204-8533, Japan.ORCID 0000-0002-2288-077X Yoko NukuiDepartment of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.ORCID 0000-0002-6123-5212 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Intravesical Bacillus Calmette-Guérin (iBCG) immunotherapy is the standard adjuvant treatment of non-muscle-invasive bladder cancer (NMIBC). Among the potential complications, cases of mycotic aneurysms and acute respiratory distress syndrome (ARDS) are rare but can be life-threatening. Because prior reports have not included whole-genome sequencing (WGS) of clinical
Indexed as
Aneurysm, InfectedBCG VaccineMycobacterium bovisRespiratory Distress SyndromeUrinary Bladder NeoplasmsAdministration, IntravesicalAgedAortic Aneurysm, AbdominalGenome, BacterialHumansMaleNon-Muscle Invasive Bladder NeoplasmsWhole Genome SequencingBCG Vaccineacute respiratory distress syndromedisseminated infectionintravesical Bacillus Calmette–GuérinMycobacterium bovismycotic aneurysmwhole-genome sequencing
Identifiers
PMID41516114
PMCPMC12785506
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390